Product information

Current status:

Cancelled Post Market

Current status date:

2006-03-22

Original market date: ^{See footnote 1}

1998-12-23

Product name:

DIAMOX SEQUELS

DIN:

02238073 Electronic product monograph is not available

Company:

WYETH CANADA
1025 Boulevard Marcel Laurin
St. Laurent
Quebec
Canada H4R 1J6

Class:

Human

Dosage form(s):

Capsule (Sustained-Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

52:40.12 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

S01EC01 ACETAZOLAMIDE

Active ingredient group (AIG) number:^{See footnote5}

0107512002